BALTIMORE (Stockpickr) -- The tail end of earnings season is in full swing this week, as another set of firms gear up to report their numbers to investors. When it comes to the opportunity for big stock moves, there's nothing quite like earnings season.
Earnings are a big deal; they're one of just four fundamental updates that investors get access to each year. So it's not surprising that earnings calls can inject some serious volatility into the broad market.
That's exactly what we're seeing this month: strong overall earnings numbers are sent the S&P 500 breaking out to new all-time highs above 1,700 last week, an important move from a technical standpoint. With a new high-water mark in equities, it's worth taking a look at five Rocket Stock names worth trading this week.
5 Best Tech Stocks To Buy For 2014: Cymer Inc.(CYMI)
Cymer, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of light sources for the manufacturers of photolithography tools in the semiconductor equipment industry. It offers installed base products in support of chipmaker customers used in their advanced wafer patterning production processes. The company also supplies deep ultraviolet light sources to lithography tool manufacturer customers, who integrate the light source into their wafer steppers and scanners, which they then provide to chipmakers. Its products include 193 nanometers (nm) ArF immersion light sources, 193 nm ArF dry light sources, and 248 nm KrF light sources. In addition, the company invests in the development of extreme ultraviolet sources for chip manufacturing. Further, it develops, integrates, markets, and supports silicon crystallization tools used in the manufacture of various types of displays, including high-resolution low temperature poly-silicon liquid c rystal displays and organic light emitting diode displays; and installed base products for use in photolithography systems used in the manufacture of semiconductors. Additionally, the company offers spare and replacement parts for light sources. Cymer, Inc. markets its products in the United States, Europe, Japan, Taiwan, South Korea, Singapore, and China. The company was founded in 1986 and is headquartered in San Diego, California.
5 Best Tech Stocks To Buy For 2014: Spansion Inc(CODE)
Codere, S.A. engages in the management of gaming machines, bingo halls, horse racing tracks, casinos, and off-track betting facilities in Argentina, Brazil, Colombia, Italy, Mexico, Spain, Panama, and Uruguay. As of December 31, 2008, the company managed 54,818 slot machines and electronic bingo terminals, 137 bingo halls with 30,803 seats, 106 off-track betting facilities, 3 horse racing tracks, and 6 casinos. It also operated 15,963 AWP machines in approximately 10,886 bars and restaurants in Spain. Codere, S.A. was founded in 1980 and is headquartered in Alcobendas, Spain.
Advisors' Opinion:- [By Michael]
The brokerage view CODE as the market leader in the embedded NOR flash memory solutions segment. Spansion has a diversified customer base of over 4,000 global customers, good design win momentum, a focused new management team, a flexible Fab Lite manufacturing strategy and recent strong revenue and earnings growth.
Since emerging from chapter 11 in May 2010, the company has executed well with four quarters of embedded flash revenue growth, regained market share of 2-3 points every quarter, achieved strong design win momentum, and generated strong cash flow from operations.
Best Casino Stocks To Watch For 2014: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By CRWE]
Gilead Sciences, Inc. (Nasdaq:GILD) reported that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada庐 (emtricitabine and tenofovir disoproxil fumarate) to reduce the risk of HIV-1 infection among uninfected adults, an HIV prevention strategy called pre-exposure prophylaxis or PrEP.
- [By Dennis Slothower]
Gilead Sciences is one of the top picks for some investors. While it may not be one of the best green stocks to invest in, the ROE and profit margin make it one to buy.
5 Best Tech Stocks To Buy For 2014: Trimble Navigation Limited(TRMB)
Trimble Navigation Limited provides positioning, wireless, and software technology solutions. The company?s Engineering and Construction segment offers site positioning systems, construction asset management services, software, and wireless and Internet-based site communications infrastructure solutions that improve productivity, accuracy, safety, and environmental impact in the entire construction process; and productivity solutions for the building construction sectors, as well as designs and markets handheld data collectors, productivity survey and mapping equipment, and data collection software for field use. Its Field Solutions segment provides guidance and positioning systems, automated application systems, and information management solutions to improve crop performance, profitability, and environmental quality; and handheld data collectors that gather information in the field. The company?s Mobile Solutions segment offers vehicle solutions, such as GPS receivers, business logic, sensor interfaces, and wireless modems; mobile worker solutions to automate service technician work in the field; and scheduling and dispatch solution, an enterprise software program to optimize scheduling and routing of field service technicians. Its Advanced Devices segment supplies global navigation satellite system modules (GNSS), licensing and complementary technologies, and GNSS-integrated sub-system solutions; supplies global positioning system receivers and embedded modules for aircraft navigation and timing applications; provides GPS-enabled cell phones for outdoor recreational activities; precision products that combine GNSS with inertial sensors; and ultra high frequency radio frequency identification reader modules, radio frequency identification readers, and design services. The company markets its products through dealers, distributors, and authorized representatives worldwide. Trimble Navigation Limited was founded in 1978 and is headquartered in Sunnyvale, California.
5 Best Tech Stocks To Buy For 2014: CEPHEID(CPHD)
Cepheid, a molecular diagnostics company, engages in developing, manufacturing, and marketing integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. The company offers GeneXpert system that integrates sample preparation in addition to DNA amplification and detection; and SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample. The GeneXpert system is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors? offices. Cepheid also provides GeneXpert Infinity System for high volume testing. The company offers tests for the GeneXpert and the SmartCycler systems in the areas of healthcare associated infections, critical infectious d isease, genetics, women?s health, and oncology. These tests include U.S. Food and Drug Administration (FDA) cleared products, CE marked products, analyte specific reagents, and research use only tests in the clinical market. In the industrial market, it sells its SmartCycler system along with general use polymerase chain reaction reagents and reaction tubes. Cepheid sells its products its direct sales force and through third-party distributors worldwide. It has collaboration agreements with Novartis, Foundation for Innovative New Diagnostics, Life Technologies Corporation, and Northrop Grumman Corporation. The company was founded in 1996 and is headquartered in Sunnyvale, California.
No comments:
Post a Comment